GARDASIL Reexamination Study (V501-059)
NCT01062074
·
clinicaltrials.gov ↗
COMPLETED
Status
3605
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Papillomavirus (HPV) Infection
Sponsor
Merck Sharp & Dohme LLC